NASDAQ:XAGE Longevity Health Q2 2025 Earnings Report $0.26 -0.05 (-16.18%) As of 06/10/2026 03:42 PM Eastern ProfileEarnings History Longevity Health EPS ResultsActual EPS-$1.56Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ALongevity Health Revenue ResultsActual Revenue$0.50 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ALongevity Health Announcement DetailsQuarterQ2 2025Date8/14/2025TimeAfter Market ClosesConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Longevity Health Earnings HeadlinesLongevity Health Announces Routine Board Member ResignationJune 4, 2026 | tipranks.comLongevity Health Holdings Closes Strategic Investment and Appoints Ram Ajjarapu as Chairman and CEO to Drive Acquisition-Focused GrowthMarch 17, 2026 | globenewswire.comALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.June 11 at 1:00 AM | Weiss Ratings (Ad)Longevity Health Holdings Ends Merger with True HealthDecember 12, 2025 | tipranks.comWhy Longevity Health Stock Is Skyrocketing TodayJuly 15, 2025 | benzinga.comWhy Longevity Health Stock Is Skyrocketing TodayJuly 15, 2025 | benzinga.comSee More Longevity Health Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Longevity Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Longevity Health and other key companies, straight to your email. Email Address About Longevity HealthCarmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.View Longevity Health ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Chewy’s Growth Engine Is Stronger Than the Market ThinksEverpure: AI Storage Uncertainty Overshadows Breakneck GrowthIntel Is the Market's Most Mispriced AI HedgeUranium Energy Corp Melts Down—Nuclear Opportunity at HandShort Sellers Are Piling Into Wingstop, But Analysts See Big UpsideOptical Cable Corporation: Strong Earnings, But Hurdles RemainThe J.M. Smucker Company’s Dividend: Too Sweet to Ignore? Upcoming Earnings Accenture (6/18/2026)FedEx (6/23/2026)Micron Technology (6/24/2026)NIKE (6/30/2026)PepsiCo (7/9/2026)Delta Air Lines (7/9/2026)Fastenal (7/13/2026)Bank of America (7/14/2026)The Goldman Sachs Group (7/14/2026)JPMorgan Chase & Co. (7/14/2026) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
